Endothelial Dysfunction - The First Step Toward Coronary Arteriosclerosis

被引:361
作者
Vanhoutte, Paul M. [1 ]
机构
[1] Univ Hong Kong, Dept Pharmacol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China
关键词
Arteriosclerosis; Endothelium; Endothelium-derived relaxing factors; Vasodilatation; NITRIC-OXIDE; DEPENDENT CONTRACTIONS; HYPERPOLARIZING FACTOR; HYDROGEN-PEROXIDE; SMOOTH-MUSCLE; NO; ATHEROSCLEROSIS; MECHANISMS; EXPRESSION; SYNTHASE;
D O I
10.1253/circj.CJ-08-1169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The endothelium causes relaxations of the underlying vascular smooth muscle, by releasing nitric oxide (NO). The endothelial cells also can evoke hyperpolarization of the vascular smooth muscle cells (endothelium-dependent hyperpolarizations, endothelium-derived hyperpolarizing factors-mediated responses). Endothelium-dependent relaxations involve both pertussis toxin-sensitive Gi and pertussis toxin-insensitive Gq coupling proteins. The endothelial release of NO is reduced in diabetes and hypertension. Arteries covered with regenerated endothelium lose the pertussis-toxin sensitive pathway for NO-release. This dysfunction favors vasospasm, thrombosis, penetration of macrophages, cellular growth and the inflammatory reaction leading to atherosclerosis. Endothelial cells also release endothelium-derived contracting factors (EDCF). Most endothelium-dependent contractions are mediated by vasoconstrictor prostanoids (endoperoxides and prostacyclin), which activate thromboxane-prostanoid (TP)-receptors of the underlying vascular smooth muscle cells. EDCF-mediated responses are augmented by aging, hypertension and diabetes. Thus, endothelial dysfunction is the first step toward coronary arteriosclerosis. (Circ J 2009; 73: 595-601)
引用
收藏
页码:595 / 601
页数:7
相关论文
共 43 条
[1]   The vulnerable atherosclerotic plaque - Pathogenesis and therapeutic approach [J].
Aikawa, M ;
Libby, P .
CARDIOVASCULAR PATHOLOGY, 2004, 13 (03) :125-138
[2]   Prostanoids and prostanoid receptors in signal transduction [J].
Bos, CL ;
Richel, DJ ;
Ritsema, T ;
Peppelenbosch, MP ;
Versteeg, HH .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (07) :1187-1205
[3]   Roads to dysfunction - Argininase II contributes to oxidized low-density lipoprotein-induced attenuation of endothelial NO production [J].
Brandes, Ralf P. .
CIRCULATION RESEARCH, 2006, 99 (09) :918-920
[4]   Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces [J].
Busse, R ;
Fleming, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (01) :24-29
[5]   EDHF:: bringing the concepts together [J].
Busse, R ;
Edwards, G ;
Félétou, M ;
Fleming, I ;
Vanhoutte, PM ;
Weston, AH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) :374-380
[6]   FLOW-MEDIATED ENDOTHELIAL MECHANOTRANSDUCTION [J].
DAVIES, PF .
PHYSIOLOGICAL REVIEWS, 1995, 75 (03) :519-560
[7]   Endothelial dysfunction in diabetes [J].
De Vriese, AS ;
Verbeuren, TJ ;
Van de Voorde, J ;
Lameire, NH ;
Vanhoutte, PM .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (05) :963-974
[8]   Nitric oxide the gatekeeper of endothelial vasomotor control [J].
Feletou, Michel ;
Tang, Eva H. C. ;
Vanhoutte, Paul M. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 :4198-4217
[9]   Endothelium-dependent hyperpolarizations:: Past beliefs and present facts [J].
Feletou, Michel ;
Vanhoutte, Paul M. .
ANNALS OF MEDICINE, 2007, 39 (07) :495-516
[10]  
Feletou Michel, 2006